MX2014011459A - Proteinas nutritivas cargadas y metodos. - Google Patents
Proteinas nutritivas cargadas y metodos.Info
- Publication number
- MX2014011459A MX2014011459A MX2014011459A MX2014011459A MX2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acid
- proteins
- acid residues
- nutritive
- ratio
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 16
- 108090000623 proteins and genes Proteins 0.000 title abstract 16
- 230000000050 nutritive effect Effects 0.000 title abstract 9
- 125000000539 amino acid group Chemical group 0.000 abstract 10
- 235000020776 essential amino acid Nutrition 0.000 abstract 2
- 239000003797 essential amino acid Substances 0.000 abstract 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
Se proveen proteínas nutritivas cargadas. En algunas modalidades, las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 12.5 g/l a pH 7. En algunas modalidades las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 50 g/l a pH 7. En algunas modalidades las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 100 g/l a pH 7. En algunas modalidades las proteínas nutritivas comprenden por lo menos uno de un nivel de a) una relación de residuos de aminoácidos de cadena ramificada a residuos de aminoácidos presentes en la proteína nutritiva igual a, o mayor que, la relación de los residuos de aminoácidos de cadena ramificada a residuos de aminoácidos totales presentes en una proteína de referencia; b) una relación de residuos de leucina a residuos de aminoácidos totales presentes en la proteína nutritiva igual que, o mayor que, la relación de residuos de leucina a residuos de aminoácidos totales presentes en una proteína de referencia; y c) una relación de residuos de aminoácidos esenciales a residuos de aminoácidos totales presentes en la proteína nutritiva igual a, o mayor que, la relación de residuos de aminoácidos esenciales a residuos de aminoácidos totales presentes en una proteína de referencia. También se proveen ácidos nucleicos que codifican las proteínas, microorganismos recombinantes que producen las proteínas, métodos para producir las proteínas usando microorganismos recombinantes, composiciones que comprenden las proteínas y métodos para usar las proteínas, entre otros.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261615816P | 2012-03-26 | 2012-03-26 | |
PCT/US2013/032212 WO2013148329A1 (en) | 2012-03-26 | 2013-03-15 | Charged nutritive proteins and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014011459A true MX2014011459A (es) | 2015-02-04 |
Family
ID=49261079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014011459A MX2014011459A (es) | 2012-03-26 | 2013-03-15 | Proteinas nutritivas cargadas y metodos. |
Country Status (13)
Country | Link |
---|---|
US (6) | US8809259B2 (es) |
EP (1) | EP2831098A4 (es) |
JP (3) | JP2015519879A (es) |
CN (1) | CN104470946A (es) |
AU (2) | AU2013240183B2 (es) |
BR (1) | BR112014023869A2 (es) |
CA (1) | CA2868522A1 (es) |
HK (1) | HK1206370A1 (es) |
IL (1) | IL234621A0 (es) |
MX (1) | MX2014011459A (es) |
RU (1) | RU2014143029A (es) |
SG (2) | SG10201604464SA (es) |
WO (1) | WO2013148329A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011041327A1 (en) * | 2009-10-01 | 2011-04-07 | The Board Of Trustees Of The Leland Stanford Junior University | Light controlled protein dimerization in cells |
JP2015519879A (ja) * | 2012-03-26 | 2015-07-16 | プロニュートリア・インコーポレイテッドPronutria, Inc. | 荷電栄養タンパク質および方法 |
EP3715365A1 (en) | 2012-03-26 | 2020-09-30 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
US9700071B2 (en) * | 2012-03-26 | 2017-07-11 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
CA2868477A1 (en) | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Nutritive proteins and methods |
MX2014011614A (es) * | 2012-03-26 | 2015-04-08 | Pronutria Inc | Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos. |
CN104936466A (zh) * | 2012-11-20 | 2015-09-23 | 普罗努塔利亚公司 | 工程化的分泌蛋白质和方法 |
WO2014134225A2 (en) * | 2013-02-26 | 2014-09-04 | Pronutria, Inc. | Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance |
AU2014324900A1 (en) | 2013-09-25 | 2016-05-19 | Axcella Health Inc. | Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment |
MY182667A (en) | 2014-08-21 | 2021-01-28 | Perfect Day Inc | Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alphalactalbumin protein |
CN114365792A (zh) | 2014-11-11 | 2022-04-19 | 克莱拉食品公司 | 用于生成卵清蛋白的方法和组合物 |
US10188135B2 (en) * | 2015-11-04 | 2019-01-29 | Stokley-Van Camp, Inc. | Method for inducing satiety |
KR102472388B1 (ko) * | 2016-03-03 | 2022-11-30 | 호유 가부시키가이샤 | 대두 알레르기의 항원 |
US20170283460A1 (en) * | 2016-04-04 | 2017-10-05 | Marpe Holdings, LLC | Immune System Modulation for Prophylaxis and Treatment of Diseases and Disorders |
AU2017314853A1 (en) | 2016-08-25 | 2019-03-14 | Perfect Day, Inc. | Food products comprising milk proteins and non-animal proteins, and methods of producing the same |
CN108208018B (zh) * | 2017-12-25 | 2020-10-16 | 中国科学院沈阳应用生态研究所 | 油松针叶精油在杀虫农药中的应用及杀虫农药组合物 |
CN108753621A (zh) * | 2018-05-30 | 2018-11-06 | 昆明理工大学 | 一种基于糖蜜废醪液提高单针藻油脂积累的方法 |
BR112021014987A2 (pt) * | 2019-01-29 | 2022-01-04 | Bond Pet Foods Inc | Composições e métodos para a produção de produtos alimentícios com proteína animal recombinante |
KR20220034848A (ko) | 2019-07-11 | 2022-03-18 | 클라라 푸드즈 컴퍼니 | 단백질 조성물 및 이의 섭취 가능한 제품 |
US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
BR102020009493A2 (pt) * | 2020-05-13 | 2021-11-23 | Bernardo De Leão Rosenmann | Composto proteico constituído pela biomassa de um organismo geneticamente modificado expressando proteínas fibrilares associado a outras fontes nutricionais provenientes de resíduos agroindustriais |
CN112480236B (zh) * | 2020-12-16 | 2022-03-29 | 熊猫乳品集团股份有限公司 | 一种生物活性肽lecvepncrskr及其制备方法和应用 |
MX2021014268A (es) * | 2021-11-19 | 2022-02-16 | Univ Mexico Nac Autonoma | Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana. |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870801A (en) * | 1968-08-09 | 1975-03-11 | Lever Brothers Ltd | Fluid aqueous protein compositions and food products prepared therefrom |
JPS585672B2 (ja) | 1975-01-16 | 1983-02-01 | フシセイユ カブシキガイシヤ | テイフエニルアラニンプラステインノセイゾウホウ |
US4342832A (en) | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
US4687782A (en) | 1984-12-10 | 1987-08-18 | Nutri-Fuels Systems, Inc. | Nutritional composition for enhancing skeletal muscle adaptation to exercise training |
US5036052A (en) | 1988-06-22 | 1991-07-30 | Morishita Pharmaceutical Co., Ltd. | Amino acid nutrient compositions |
JP3111237B2 (ja) * | 1990-11-14 | 2000-11-20 | 大塚製薬株式会社 | 肝疾患患者用組成物 |
AU4244793A (en) | 1992-05-12 | 1993-12-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona, The | Human cell cycle checkpoint genes |
GB9310472D0 (en) | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
DE4442668C2 (de) | 1994-11-30 | 1997-09-18 | Milupa Ag | Verfahren zur Herstellung einer phenylalaninfreien Säuglings- und Kleinkindernahrung |
WO1996017064A1 (en) | 1994-12-02 | 1996-06-06 | Indiana University Foundation | Phenylalanine free proteins |
GB9614700D0 (en) | 1996-07-12 | 1996-09-04 | Medical Res Council | Over-expression of proteins in E.Coli |
US6800726B1 (en) | 1996-11-01 | 2004-10-05 | Pioneer Hi-Bred International, Inc. | Proteins with increased levels of essential amino acids |
US6291245B1 (en) | 1998-07-15 | 2001-09-18 | Roche Diagnostics Gmbh | Host-vector system |
US6630320B1 (en) | 2000-05-08 | 2003-10-07 | Devisco Foods International, Inc. | Treatment of hypertension in mammals with hydrolyzed whey proteins |
US20110131679A2 (en) * | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
US20060159724A1 (en) | 2000-08-08 | 2006-07-20 | Bell Stacey J | Nutritional supplement for the management of weight |
US7214786B2 (en) | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
BR0208136B1 (pt) | 2001-03-30 | 2014-10-21 | Ajinomoto Kk | Método para produzir uma proteína heteróloga |
GB0110288D0 (en) | 2001-04-26 | 2001-06-20 | Novartis Nutrition Ag | Composition and treatment method |
US20040266689A1 (en) * | 2002-01-16 | 2004-12-30 | Mcmichael John | Use of calmodulin to promote bone regeneration |
US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
DE60216523T2 (de) | 2002-06-19 | 2007-10-04 | Centro de Investigacion en Alimentacion y Desarrollo, A.C., Hermosillo | Herstellung und verwendung von mit verzweigten aminosäuren angereicherten sojaproteinhydrolysaten |
US20040087490A1 (en) | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US7273738B2 (en) | 2002-10-01 | 2007-09-25 | Novozymes A/S | Family GH-61 polypeptides |
US7445807B2 (en) | 2002-10-15 | 2008-11-04 | Western Holdings, Llc | Agglomerated granular protein-rich nutritional supplement |
US9288998B2 (en) * | 2002-11-06 | 2016-03-22 | Medwell Foods, Inc. | Edible nutritive composite |
WO2004052385A1 (ja) | 2002-12-06 | 2004-06-24 | Sunstar Inc. | 緑黄色野菜及び淡色野菜を含有する組成物 |
US6814983B2 (en) * | 2002-12-10 | 2004-11-09 | Everett Laboratories, Inc. | Compositions and methods for nutrition supplementation |
EP2272864A3 (en) | 2002-12-20 | 2011-02-16 | Amgen Inc. | Binding agents which inhibit myostatin |
US7288570B2 (en) | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
US6812249B2 (en) | 2003-03-04 | 2004-11-02 | Sal Abraham | Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use |
US20060150283A1 (en) | 2004-02-13 | 2006-07-06 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
US20110183052A1 (en) | 2004-10-07 | 2011-07-28 | Next Proteins, Inc. | Protein beverage and method of making the same |
WO2006047308A2 (en) * | 2004-10-21 | 2006-05-04 | Iowa State University Research Foundation, Inc. | Novel vegetable protein fractionization process and compositions |
WO2006099207A2 (en) | 2005-03-10 | 2006-09-21 | Diversa Corporation | Lyase enzymes, nucleic acids encoding them and methods for making and using them |
EP2949756A3 (en) | 2005-03-15 | 2016-02-24 | BP Corporation North America Inc. | Cellulases, nucleic acids encoding them and methods for making and using them |
JP5545424B2 (ja) | 2005-03-29 | 2014-07-09 | 味の素株式会社 | 高齢者の骨格筋量減少を防止又は改善するためのアミノ酸含有組成物 |
ATE487390T1 (de) * | 2005-08-23 | 2010-11-15 | Herberger Dr Armand | Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs |
NZ567517A (en) | 2005-09-21 | 2011-09-30 | Burcon Nutrascience Mb Corp | Preparation of canola protein isolate involving isoelectric precipitation |
CN101316518B (zh) | 2005-10-26 | 2012-07-11 | 希尔氏宠物营养品公司 | 用于增加瘦肉量和/或减少脂肪增量的组合物和方法 |
AU2006309040B2 (en) | 2005-10-28 | 2011-10-06 | Nestec S.A. | Methods for the use of branched chain amino acids |
CN101316582A (zh) | 2005-11-30 | 2008-12-03 | 雀巢技术公司 | 治疗肌肉损失的方法 |
EP1968994B1 (en) | 2005-12-06 | 2013-07-03 | Synthetic Genomics, Inc. | Synthetic genomes |
US20090304901A1 (en) | 2006-01-25 | 2009-12-10 | Steven Craig Bobzin | Modulating plant protein levels |
BRPI0621457A2 (pt) | 2006-03-01 | 2012-04-17 | Gen Mills Marketing Inc | processo de acidificação pós-congelamento de produtos lácteos congelados e produtos resultantes |
AU2007223086B2 (en) | 2006-03-07 | 2013-09-26 | Basf Enzymes Llc | Aldolases, nucleic acids encoding them and methods for making and using them |
DK2069490T4 (en) | 2006-12-21 | 2018-04-23 | Syngenta Participations Ag | Amylases and Glucoamylases, Nucleic Acids Encoding Them, and Methods of Preparation and Use thereof |
US20080206430A1 (en) | 2007-02-22 | 2008-08-28 | Rafael Avila | Compositions consisting of blended vegetarian proteins |
US20080268038A1 (en) | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
WO2008156868A2 (en) | 2007-06-20 | 2008-12-24 | Baum Seth J | Compositions and methods of treating chronic kidney disease |
US20110183040A1 (en) | 2007-08-03 | 2011-07-28 | Ermolin Gennady A | Amino Acid and Peptide Products |
EP2036978A1 (en) | 2007-09-14 | 2009-03-18 | URSAPHARM Arzneimittel GmbH & Co. KG | Recombinant preparation of selected bromelain fractions |
US20090252684A1 (en) | 2007-12-10 | 2009-10-08 | Wolfe Robert R | Determination of tissue-specific profile of amino acid requirements form the relationship between the amounts of tRNAs for individual amino acids and the protein-bound amino acid profile of the tissue |
US7790688B2 (en) | 2008-01-11 | 2010-09-07 | Healthspan Solutions, Llc | Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
US8716249B2 (en) | 2008-01-31 | 2014-05-06 | Energy Light Llc | Compositions and methods for improving cardiovascular health |
US20090203606A1 (en) | 2008-02-05 | 2009-08-13 | Wolfe Robert R | Systems for and Methods of use of Therapeutic Nutrition for the Management of Age-Associated and Age-Specific Health Conditions of the Elderly |
US8029830B2 (en) | 2008-04-18 | 2011-10-04 | Nuvocare Health Services Inc. | Composition and method for promoting internal health and external appearance |
GB0812649D0 (en) | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
AU2009203213A1 (en) * | 2008-08-04 | 2010-02-18 | Cereal Ingredients, Inc. | Food particle for promoting wellness |
US20100055246A1 (en) | 2008-08-28 | 2010-03-04 | Dong June Ahn | Nutrition delivery capsules for functional foods |
CN103005464B (zh) | 2008-10-17 | 2015-01-07 | 雀巢产品技术援助有限公司 | 乳清蛋白组合物、方法及用途 |
US20100179089A1 (en) | 2009-01-13 | 2010-07-15 | Deutz Nicolaas E P | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
MX2011009396A (es) | 2009-03-12 | 2011-09-28 | Ind Nutrigrains S A De C V | Proteina vegetal hibrida y metodo para obtener la misma. |
US20120178672A1 (en) | 2009-03-18 | 2012-07-12 | Wolfe Robert R | Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis |
WO2010126353A1 (en) | 2009-04-27 | 2010-11-04 | N.V. Nutricia | Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding |
US8604168B2 (en) | 2009-06-12 | 2013-12-10 | Wisconsin Alumni Research Foundation | Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders |
US20120171348A1 (en) * | 2009-06-30 | 2012-07-05 | Segall Kevin I | Production of acid soluble soy protein isolates ("s800") |
CA2772996A1 (en) | 2009-09-02 | 2011-03-10 | Team Foods Colombia S.A. | Composition with high-protein content for the food industry |
CA2779161A1 (en) | 2009-10-28 | 2011-05-05 | University Of Manitoba | Yellow pea seed protein-derived peptides |
WO2011078654A1 (en) | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
CA2786307A1 (en) | 2010-01-06 | 2011-07-14 | Cargill, Incorporated | High protein cooked product |
ES2478869T3 (es) | 2010-01-29 | 2014-07-23 | N.V. Nutricia | Composición nutricional enteral líquida adecuada para alimentación por sonda |
JP2011184314A (ja) | 2010-03-04 | 2011-09-22 | Snow Brand Milk Products Co Ltd | 筋肉萎縮防止剤 |
WO2011119023A1 (en) | 2010-03-26 | 2011-09-29 | N.V. Nutricia | Low protein infant formula with increased essential amino acids |
WO2012006074A1 (en) * | 2010-06-28 | 2012-01-12 | Nestec S.A. | Hypocaloric, high protein nutritional compositions and methods of using same |
CN101886107A (zh) | 2010-07-02 | 2010-11-17 | 广东海洋大学 | 一种酶法制备马氏珠母贝高f值寡肽的方法 |
WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
EP2592944B1 (en) | 2010-07-18 | 2019-12-25 | Glanbia Nutritionals (Ireland) Ltd. | High-protein beverages comprising whey protein |
EP3957182A1 (en) * | 2010-08-18 | 2022-02-23 | Burcon Nutrascience (MB) Corp. | Improved production of protein solutions from soy |
WO2013075095A1 (en) | 2011-11-18 | 2013-05-23 | The Board Of Trustees Of The University Of Arkansas | Use of amino acid supplementation for improved muscle recovery |
EP2794911A1 (en) | 2011-12-22 | 2014-10-29 | Aveo Pharmaceuticals, Inc. | Identification of multigene biomarkers |
KR20140121475A (ko) | 2012-02-06 | 2014-10-15 | 아지노모토 가부시키가이샤 | 특발성 염증성 근질환의 예방 또는 치료제 |
EP2831101A4 (en) | 2012-03-26 | 2016-01-06 | Pronutria Inc | CHARGED NUTRIENT FRAGMENTS, PROTEINS AND METHODS |
JP2015519879A (ja) * | 2012-03-26 | 2015-07-16 | プロニュートリア・インコーポレイテッドPronutria, Inc. | 荷電栄養タンパク質および方法 |
US9700071B2 (en) * | 2012-03-26 | 2017-07-11 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
EP3715365A1 (en) | 2012-03-26 | 2020-09-30 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
WO2013163654A2 (en) | 2012-04-27 | 2013-10-31 | Pronutria, Inc. | Nucleic acids, cells, and methods for producing secreted proteins |
WO2014134225A2 (en) | 2013-02-26 | 2014-09-04 | Pronutria, Inc. | Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance |
AU2014324900A1 (en) | 2013-09-25 | 2016-05-19 | Axcella Health Inc. | Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment |
-
2013
- 2013-03-15 JP JP2015503331A patent/JP2015519879A/ja active Pending
- 2013-03-15 WO PCT/US2013/032212 patent/WO2013148329A1/en active Application Filing
- 2013-03-15 US US13/836,855 patent/US8809259B2/en active Active
- 2013-03-15 SG SG10201604464SA patent/SG10201604464SA/en unknown
- 2013-03-15 AU AU2013240183A patent/AU2013240183B2/en active Active
- 2013-03-15 BR BR112014023869A patent/BR112014023869A2/pt not_active IP Right Cessation
- 2013-03-15 RU RU2014143029A patent/RU2014143029A/ru not_active Application Discontinuation
- 2013-03-15 SG SG11201405842PA patent/SG11201405842PA/en unknown
- 2013-03-15 EP EP13767426.3A patent/EP2831098A4/en not_active Withdrawn
- 2013-03-15 CN CN201380027476.8A patent/CN104470946A/zh active Pending
- 2013-03-15 MX MX2014011459A patent/MX2014011459A/es unknown
- 2013-03-15 CA CA2868522A patent/CA2868522A1/en not_active Abandoned
-
2014
- 2014-03-19 US US14/219,943 patent/US8822412B2/en active Active
- 2014-07-22 US US14/337,563 patent/US9611298B2/en active Active
- 2014-09-11 IL IL234621A patent/IL234621A0/en unknown
-
2015
- 2015-07-24 HK HK15107104.1A patent/HK1206370A1/xx unknown
-
2017
- 2017-01-13 AU AU2017200234A patent/AU2017200234B2/en active Active
- 2017-02-10 US US15/429,420 patent/US10450350B2/en active Active
-
2018
- 2018-04-04 JP JP2018072592A patent/JP6853801B2/ja active Active
-
2019
- 2019-09-10 US US16/566,734 patent/US20200109175A1/en not_active Abandoned
-
2021
- 2021-03-12 JP JP2021040044A patent/JP7303238B2/ja active Active
-
2023
- 2023-10-10 US US18/378,229 patent/US20240150406A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20170246244A1 (en) | 2017-08-31 |
US20200109175A1 (en) | 2020-04-09 |
US20140342978A1 (en) | 2014-11-20 |
BR112014023869A2 (pt) | 2017-07-18 |
US20240150406A1 (en) | 2024-05-09 |
JP7303238B2 (ja) | 2023-07-04 |
EP2831098A4 (en) | 2016-12-07 |
US8809259B2 (en) | 2014-08-19 |
JP6853801B2 (ja) | 2021-03-31 |
WO2013148329A1 (en) | 2013-10-03 |
AU2017200234A1 (en) | 2017-02-02 |
JP2021097700A (ja) | 2021-07-01 |
US20130296231A1 (en) | 2013-11-07 |
US10450350B2 (en) | 2019-10-22 |
EP2831098A1 (en) | 2015-02-04 |
AU2013240183A1 (en) | 2014-10-09 |
CN104470946A (zh) | 2015-03-25 |
HK1206370A1 (en) | 2016-01-08 |
SG10201604464SA (en) | 2016-07-28 |
IL234621A0 (en) | 2014-11-30 |
AU2017200234B2 (en) | 2017-06-08 |
JP2015519879A (ja) | 2015-07-16 |
AU2013240183B2 (en) | 2016-10-20 |
US20140212541A1 (en) | 2014-07-31 |
US9611298B2 (en) | 2017-04-04 |
RU2014143029A (ru) | 2016-05-20 |
SG11201405842PA (en) | 2014-10-30 |
JP2018139589A (ja) | 2018-09-13 |
US8822412B2 (en) | 2014-09-02 |
CA2868522A1 (en) | 2013-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014011459A (es) | Proteinas nutritivas cargadas y metodos. | |
MX2014011614A (es) | Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos. | |
MX2014011600A (es) | Proteínas nutritivas, fragmentos y métodos. | |
MX2013012844A (es) | Secuencias de aminoacidos dirigidas contra il-17a, il-17f y/o il-17a/f y polipeptidos que comprenden las mismas. | |
MY160552A (en) | Low protein infant formula with increased essential amino acids | |
IN2014CN00414A (es) | ||
MX352823B (es) | Formulaciones de proteinas que contienen aminoacidos. | |
MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
WO2015031726A3 (en) | Engineered primate l-methioninase for therapeutic purposes | |
IN2014DN09922A (es) | ||
EA201590611A1 (ru) | Новые молекулы, связывающие il-17a, и их медицинское применение | |
EA201691011A1 (ru) | Последовательность модифицированного эндолизина el188 | |
MX2022012042A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
IN2015DN03206A (es) | ||
MX354156B (es) | Dipeptido que comprende un aminoacido no proteogenico. | |
MX2017008934A (es) | Método para obtener un aislado de péptidos a partir de una biomasa de microalgas enriquecidas en proteínas. | |
PH12017502323A1 (en) | Novel xylanase | |
CO2017011431A2 (es) | Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina | |
PH12020551955A1 (en) | Anti-cd63 antibodies, conjugates, and uses thereof | |
EA201691004A1 (ru) | Последовательность модифицированного эндолизина kz144 | |
WO2014194129A3 (en) | Cell-free synthetic incorporation of non-natural amino acids into proteins | |
NZ709120A (en) | Beta-hexosyl-transferases and uses thereof | |
WO2016036635A8 (en) | Chromobacterium subtsugae genes | |
WO2009105780A3 (en) | Mntf peptide compositions and methods of use | |
WO2015108856A3 (en) | Methods for enhancing the delivery of active agents |